Risk adjusted net present value: What is the current valuation of Jazz Pharmaceuticals’s JZP-898?
The revenue for JZP-898 is expected to reach an annual total of $16 mn by 2040 in the US based off GlobalData’s Expiry Model. The drug’s revenue forecasts along with estimated costs are used to measure the value of an investment opportunity in that drug, …